June #113 : Hepatitis on the Block

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Fighting Femmes

The amfAR's new clothes

Warm Reception

White Smoke In Our Eyes

Hepatitis on the Block

High On Adherence

A Positive Campaign

Founder's Letter

Earthwatch: Generic Meds

On The March!



POZ Picks Gay Pride

Medi - Mess

How to Treat "Untreatable" HIV

Read It Or Weep

Live and Let Die?

Did Common Just Come Out?

Legal Eye

Quick Study


Book nook


When Push Comes To Drag

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

June 2005

Hepatitis on the Block

• In February, the FDA approved Roche’s hepatitis C treatment—Pegasys (peginterferon alfa-2a) plus Copegus (ribavirin USP)—for HIVers coinfected with hep C. Many coinfected folks have been using the combo (with cure rates ranging from 27% to 40% in studies) since its 2002 approval for hep C soloists.

• In a small study, Pegasys and methadone didn’t interact badly, so dose adjustments aren’t necessary if you’re taking both. Ribavirin hasn’t been similarly tested, but folks hip to hep C think it won’t mess with meth, either.

• In March, the FDA approved BMS’s Baraclude (entecavir) for hep B treatment. The FDA doesn’t say the drug is “indicated” for use in HIVers, but the label tells docs how to dose the med for B-bearing HIVers who have previously taken lamivudine (3TC). Baraclude remains to be studied in HIVers who’ve never taken 3TC. 

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.